Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v20-EN Version v14-FR
Language English French
Date Updated 2024-02-14 2023-05-30
Drug Identification Number 02212307 02212307
Brand name CEFTIN CEFTIN
Common or Proper name CEFTIN CEFTIN
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients CEFUROXIME CEFUROXIME
Strength(s) 125MG 125MG
Dosage form(s) GRANULES FOR SUSPENSION GRANULES FOR SUSPENSION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 70ML 70ML
ATC code J01DC J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2022-10-19 2022-10-19
Estimated end date 2023-10-06 2023-07-24
Actual end date 2023-10-02
Shortage status Resolved Actual shortage
Tier 3 Status No Yes
Company comments
Health Canada comments